ArticleClinical cancer research : an official journal of the American Association for Cancer Research2026

Ibrutinib and PD-1 Blockade Potentiate Mesothelin-Targeting CAR T-cell Therapy in Preclinical Models of Pancreatic Cancer.

Alexander Armstrong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.